Pfizer Inc. (PFE) Q1 2017 Earnings Results

Pfizer Beats on EPS, Stock Down 0.5%

Pfizer's earnings report showed a slight beat on EPS, which is a positive sign for investors. However, the stock reacted negatively, dropping 0.5%. The lack of revenue information and guidance may have contributed to investor uncertainty.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.69	N/A	+1.19%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Overall, management conveyed a cautious optimism regarding their earnings performance. They highlighted the importance of upcoming product developments.

Management expressed satisfaction with the EPS performance despite the lack of revenue details.

The focus remains on future product pipelines and market strategies.

Pfizer Beats on EPS, Stock Down 0.5%

Key numbers

Management commentary

Pfizer Inc.

More earnings this week

Pfizer Beats on EPS, Stock Down 0.5%

Key numbers

Management commentary